Osteoporosis Risk Reduced by Targeting Hormonal Receptor Proteins

Reduced levels of sex hormones in men, caused by prostate cancer therapy can lead to lower vitamin D levels, which in turn increases the risk of bone fractures. This study has identified a previously unknown link between male sex hormone levels and vitamin D that may have future therapeutic value for treating related deficiencies of the vitamin. Progesterone receptor protein, a new regulator of vitamin D metabolism, can now be targeted to prevent osteoporosis in men finds a new study.